EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Kavain for health promotion and disease mitigation: Pharmacological promise and therapeutic perspectives

Nath Pampita, Anjana Sajeev, Mangala Hegde, Mohammed S Alqahtani, Mohamed Abbas, Joachim Kavalakatt, Gautam Sethi, Anupam Bishayee, Ajaikumar B Kunnumakkara

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2026.158017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Phytomedicine, 2026. Verfasst von Nath Pampita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati (IITG), Guwahati 781 039, Assam, Ind…. Hauptthemen laut MEDLINE: Kava. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 163 Literaturangaben. Gefördert von: Indian Institute of Technology Guwahati, Department of Biotechnology, Ministry of Science and Technology, India, Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chronic diseases remain a predominant cause of mortality worldwide despite existing therapies, which often have side effects and high costs. Natural compounds, such as kavain from Piper methysticum, have attracted attention for their therapeutic potential and safety, showing diverse biological activities useful in treating various health conditions. PURPOSE: This study aimed to assess the potential role of kavain in the prevention and treatment of chronic diseases, with a particular focus on its anti-inflammatory, anxiolytic, antithrombotic, neuroprotective, and anticancer properties. METHOD: A comprehensive literature search on kavain was conducted using PubMed, Scopus, Science direct and Web of Science databases, considering both preclinical and clinical studies. The term "kavain" was used, and all titles, abstracts, and keywords were screened for relevant information. RESULTS: Findings from various experimental models suggest that kavain exhibits significant biological and pharmacological activities across various pathological conditions, including inflammation, anxiety, neurological disorders, cardiovascular diseases, and cancer. Pharmacokinetic studies reveal its rapid absorption, moderate oral bioavailability, and efficient systemic clearance. Mechanistically, kavain regulates various molecular pathways including nuclear factor-κB and mitogen-activated protein kinase signaling, modulation of γ-aminobutyric acid type A receptor activity, and inhibition of osteoclastogenesis. Toxicity studies indicate that kavain is well-tolerated at physiologically relevant concentrations. Clinical reports show its anxiolytic potential with favorable safety profile. CONCLUSION: Kavain has demonstrated considerable therapeutic potential in the prevention and management of various chronic diseases, with relatively few adverse effects. Consequently, further clinical investigations will be beneficial to validate its efficacy and safety in human populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KavaHumansAnimalsNeuroprotective AgentsAnti-Inflammatory AgentsChronic DiseaseAnti-Anxiety AgentsHealth PromotionFibrinolytic Agents

Stichwörter der Autor:innen

Anti-inflammatoryChronic diseasesKavainNeuroprotectionPiper methysticum

Substanzen

Neuroprotective AgentsAnti-Inflammatory AgentsAnti-Anxiety AgentsFibrinolytic Agents

Autor:innen und Institutionen

  • Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati (IITG), Guwahati 781 039, Assam, India.
  • Radiological Sciences Department, College of Applied Medical Sciences, King Khalid University, Abha 61421, Saudi Arabia; BioImaging Unit, Space Research Centre, University of Leicester, Leicester LE1 7RH, UK.
  • Electrical Engineering Department, College of Engineering, King Khalid University, Abha 61421, Saudi Arabia.
  • Department of Pharmacology, College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA.
  • Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.
  • Department of Pharmacology, College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA. Electronic address: abishayee@lecom.edu.

Förderung

  • Indian Institute of Technology Guwahati
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Council of Scientific and Industrial Research, India
  • King Khalid University
  • Ministry of Education, India

Zitieren

APA

Pampita, N., Sajeev, A., Hegde, M., Alqahtani, M. S., Abbas, M., Kavalakatt, J., Sethi, G., Bishayee, A., & Kunnumakkara, A. B. (2026). Kavain for health promotion and disease mitigation: Pharmacological promise and therapeutic perspectives. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158017

Vancouver

Pampita N, Sajeev A, Hegde M, Alqahtani MS, Abbas M, Kavalakatt J, et al. Kavain for health promotion and disease mitigation: Pharmacological promise and therapeutic perspectives. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158017

BibTeX
@article{Pampita2026,
  author = {Pampita, Nath and Sajeev, Anjana and Hegde, Mangala and Alqahtani, Mohammed S and Abbas, Mohamed and Kavalakatt, Joachim and Sethi, Gautam and Bishayee, Anupam and Kunnumakkara, Ajaikumar B},
  title = {Kavain for health promotion and disease mitigation: Pharmacological promise and therapeutic perspectives},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2026.158017}
}
Kostenlos starten →